☆ 4.5 Article

Correlation Analysis Between Demographic, Surgical, and Pathological Characteristics with Local Recurrence-Free Survival for Surgical Resected Retroperitoneal Liposarcoma

WORLD JOURNAL OF SURGERY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center

Elise F. Nassif et al.

Summary: This study reports on the real-world use and surgical outcomes associated with palbociclib treatment for patients with retroperitoneal WDLPS or DDLPS. The findings indicate that palbociclib monotherapy for advanced WDLPS and DDLPS is disappointing in terms of efficacy.

INTERNATIONAL JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer

Ina Valeria Zurlo et al.

Summary: The study found that pre-treatment NLR, TILs, and PD-L1 expression are correlated with the response to neoadjuvant chemotherapy and prognosis in LAGC patients, suggesting their significance in selecting patients for chemotherapy.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Add to Collection

Article Oncology

Development and Validation of a Prognostic Model to Predict the Prognosis of Patients With Retroperitoneal Liposarcoma: A Large International Population-Based Cohort Study

Yiding Li et al.

Summary: This study constructed and validated an unprecedented nomogram prognostic model for patients with RPLs, involving 1,392 patients from the SEER database and internal and external validation cohorts. The nomogram provided a good assessment of survival and cancer-specific survival at 1, 3, and 5 years for RPLs patients, with predicted survival rates closely corresponding to actual survival rates.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Oncology

Role of Radiation Therapy in Retroperitoneal Sarcoma

Kilian E. Salerno et al.

Summary: Retroperitoneal sarcoma is a rare form of soft tissue sarcoma, and surgery is the primary treatment modality. However, recurrence is common even with complete resection. The use of radiation therapy in this disease is controversial, and there is insufficient data to guide management decisions.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Add to Collection

Article Oncology

A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center

Guoqiang Xue et al.

Summary: The study aimed to establish a postoperative nomogram for RLPS to predict LRFS. Factors such as FNCLCC grade and completeness of resection were identified as independent predictors of LRFS. The nomogram demonstrated a concordance index of 0.732, with excellent calibration.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Surgery

Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience*

Noriyuki Masaki et al.

Summary: A retrospective study of 40 patients with primary retroperitoneal liposarcoma revealed that patients with initial WDLS had favorable prognosis despite multiple recurrences, while those with DDLS/myxoid subtype had lower survival rates after developing distant metastases.

ASIAN JOURNAL OF SURGERY (2021)

Add to Collection

Article Surgery

The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma

Michael J. Littau et al.

Summary: In this study, 4018 patients with retroperitoneal liposarcoma were analyzed. Positive surgical margins were associated with increased risk of death across all tumor size categories, while adjuvant radiotherapy was only linked to improved survival in patients with large tumors (>10 cm). Radiotherapy should be used cautiously in patients with smaller tumors.

AMERICAN JOURNAL OF SURGERY (2021)

Add to Collection

Article Oncology

Diagnosis and Prognosis of Retroperitoneal Liposarcoma: A Single Asian Center Cohort of 57 Cases

Jianchun Xiao et al.

Summary: Liposarcoma is a soft tissue malignancy commonly found in the extremities, with retroperitoneal liposarcoma often neglected in diagnosis. Chief complaints include abdominal distension and pain. R0 resection is crucial for treatment, while patients who undergo R2 resection have poorer prognoses. Large, symptomatic dedifferentiated liposarcomas tend to have worse outcomes, while well-differentiated or myxoid liposarcoma have relatively better prognoses.

JOURNAL OF ONCOLOGY (2021)

Add to Collection

Article Oncology

Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases

Pingping Sun et al.

Summary: This study analyzed the pathological characteristics and prognostic factors of 124 cases of retroperitoneal liposarcoma, finding that age, tumor necrosis, tumor site, and recurrence are independent pathological prognostic factors for RLS.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Pathology

Retroperitoneal Dedifferentiated Liposarcoma: The Presence of the Dedifferentiated Component at the Resection Margin Is Associated With Shorter Recurrence-Free Survival

Carina A. Dehner et al.

Summary: The presence of the dedifferentiated (DD) component at the resection margin in retroperitoneal dedifferentiated liposarcoma (DDLS) is associated with worse local recurrence-free survival (LRFS), but does not significantly impact overall survival (OS). Reporting the presence or absence of DD tumor at the margin in retroperitoneal DDLS is recommended for providing meaningful prognostic information.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Article Oncology

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

A. Gronchi et al.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Review Oncology

The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer: A systematic review and meta-analysis

Mate Naszai et al.

Summary: Inflammation is closely related to cancer, and NLR from routine blood testing serves as an easily accessible prognostic biomarker, aiding in assessing clinical outcomes in colorectal cancer patients. Combining results from numerous studies, high NLR was found to be associated with poor clinical outcomes, despite limitations in some studies, it should be routinely collected in clinical trials.

CANCER MEDICINE (2021)

Add to Collection

Review Oncology

Emerging and multifaceted role of neutrophils in lung cancer

Christian Aloe et al.

Summary: It is well-known that smoking is a common risk factor for lung cancer and COPD, with the severity of COPD increasing the risk of lung cancer development independently of smoking history. Neutrophilic inflammation escalates with COPD severity and non-steroidal anti-inflammatory drugs can modulate neutrophil function and cancer risk. Neutrophils in lung cancer, especially in smokers with NSCLC, increase in density as tumors progress, responding to the tumor microenvironment and polarizing into different phenotypes with either anti-tumor or pro-tumorigenic effects.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Add to Collection

Review Pathology

The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives

Marta Sbaraglia et al.

Summary: Mesenchymal tumors, especially those in challenging diagnostic pathology, are greatly impacted by the refinement of classification schemes as it improves the quality of pathologic diagnosis and therapeutic options. The recent 2020 WHO classification of Soft Tissue Tumours and Bone, open to expert clinicians, has stimulated a debate on the importance of pathologic diagnosis and precision oncology. Pathologic diagnosis, integrating morphologic, immunohistochemical and molecular characteristics, plays a crucial role in clinical decision making and the WHO classification serves as a key instrument in promoting multidisciplinary efforts for more effective treatments.

PATHOLOGICA (2021)

Add to Collection

Review Surgery

Multidisciplinary Oncovascular Surgery is Safe and Effective in the Treatment of Intra-abdominal and Retroperitoneal Sarcomas: A Retrospective Single Centre Cohort Study and a Comprehensive Literature Review

Pauliina Homsy et al.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2020)

Add to Collection

Article Oncology

Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab

A. Simonaggio et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Add to Collection

Article Oncology

Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution

Kenta Ishii et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Resection outcomes for primary and local recurrent retroperitoneal liposarcoma patients

Yang Yan et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments

Lorena P. Suarez-Kelly et al.

EXPERT OPINION ON PHARMACOTHERAPY (2019)

Add to Collection

Review Oncology

Multiply recurrent retroperitoneal liposarcoma

Sanjay P. Bagaria et al.

JOURNAL OF SURGICAL ONCOLOGY (2018)

Add to Collection

Article Orthopedics

Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution

Francesco Muratori et al.

JOURNAL OF ORTHOPAEDIC SCIENCE (2018)

Add to Collection

Article Surgery

Risk factors of early recurrence in retroperitoneal liposarcoma

Juan Manuel Sanchez-Hidalgo et al.

CIRUGIA ESPANOLA (2018)

Add to Collection

Article Oncology

Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: The Gustave Roussy experience

Honore Charles et al.

JOURNAL OF SURGICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma

George Molina et al.

JOURNAL OF SURGICAL ONCOLOGY (2016)

Add to Collection

Article Oncology

Long-Term Outcomes in Treatment of Retroperitoneal Sarcomas: A 15 Year Single-Institution Evaluation of Prognostic Features

Eihab Abdelfatah et al.

JOURNAL OF SURGICAL ONCOLOGY (2016)

Add to Collection

Review Oncology

The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer

Graeme J. K. Guthrie et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)

Add to Collection

Article Surgery

Surgical management of primary and recurrent retroperitoneal liposarcoma

SJ Neuhaus et al.

BRITISH JOURNAL OF SURGERY (2005)

Add to Collection

Article Surgery

Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma

S Singer et al.

ANNALS OF SURGERY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.